With Insulin Sensitivity, It's Matter Over Mind

Article

Insulin sensitivity impairs the inferior parietal lobe in the obese, indicating a new target for identifying cognitive decline in the middle-aged.

Because of impairments in their insulin sensitivity, obese individuals demonstrate different brain responses than their normal-weight peers while completing a challenging cognitive task, according to new research by psychologists at The University of Texas at Austin.

The results provide further evidence that a healthy lifestyle at midlife could lead to a higher quality of life later on, especially as new drugs and treatments allow people to live longer.

Obesity

"The good thing about insulin sensitivity is that it's very modifiable through diet and exercise," says psychology graduate student Mitzi Gonzales, who co-authored the paper published in the journal with Assistant Professor Andreana Haley and other colleagues.

To better understand why midlife obesity is linked to higher risk of cognitive decline and dementia in old age, the researchers had middle-aged adults between 40 and 60 years of age complete a challenging cognitive task while undergoing functional magnetic resonance imaging (fMRI).

While obese, overweight, and normal-weight participants performed equally well on the task, obese individuals displayed lower functional brain response in one brain region, the inferior parietal lobe.

Obese participants also had lower insulin sensitivity than their normal weight and overweight peers, meaning that their bodies break down glucose less efficiently. Poor insulin sensitivity may ultimately lead to diabetes mellitus if the pancreas is unable to secrete enough insulin to compensate for reduced glucose use.

The study shows that impaired insulin sensitivity, which generally accompanies obesity, may serve as a mediator between midlife obesity and cognitive decline later on. Researchers chose to examine insulin sensitivity because insulin helps regulate people's metabolism and also affects cognitive functions.

The study exemplifies the aim of Haley's lab, which is to use neuroimaging in middle-aged individuals to provide early identification of risk for cognitive decline later in life.

"Generally, very few people study the middle-aged segment of the population, but that's when many chronic diseases are first identified and neurodegenerative processes are triggered," says Haley. "We found that while behavioral performance of obese middle-aged individuals may be the same — they can complete the same cognitive tasks as normal weight individuals — their brain is already doing something different to produce that outcome."

Haley and Gonzales are planning a follow up study to determine if a 12-week exercise intervention can reverse the observed differences in brain response.

Source: University of Texas at Austin

Related Videos
Laxmi Mehta, MD | Credit: American Heart Association
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
Erin Michos, MD | Credit: Johns Hopkins University
© 2024 MJH Life Sciences

All rights reserved.